期刊撤回25年前孟山都支持的除草剂论文

Core Viewpoint - A significant paper published in 2000, which claimed that glyphosate, a herbicide widely used by Monsanto, does not cause cancer, has been retracted due to serious ethical issues and questions regarding the validity of its conclusions [2][5] Group 1: Retraction and Ethical Concerns - The retraction was prompted by internal emails from Monsanto that revealed employees assisted in writing the influential paper, raising doubts about its integrity [2] - The retraction statement highlighted "serious ethical issues" and the questionable validity of the research conclusions [2] - The authors of the paper primarily reviewed unpublished research from Monsanto while neglecting external studies, potentially leading to biased conclusions [6] Group 2: Impact and Ongoing Controversy - The paper was cited in the top 0.1% of glyphosate-related academic research, and its citation rate remained largely unchanged even after the connection to Monsanto was revealed [3] - Despite the International Agency for Research on Cancer (IARC) classifying glyphosate as "probably carcinogenic," the U.S. Environmental Protection Agency (EPA) and the European Chemicals Agency (ECHA) have not adopted this conclusion, with the EPA stating glyphosate is "unlikely" to be carcinogenic [6] - Bayer, which now owns Monsanto, stated that the retracted study is just one of many studies on glyphosate's safety, asserting that major regulatory agencies agree on its safety when used as directed [6]